Home > Healthcare > Analytical Instruments > Molecular Analysis > Bioanalytical Testing Services Market

Bioanalytical Testing Services Market Size

  • Report ID: GMI8443
  • Published Date: Mar 2024
  • Report Format: PDF

Bioanalytical Testing Services Market Size

Bioanalytical Testing Services Market was valued at USD 3.8 billion in 2023 and is set to achieve over 8.6% CAGR from 2024 to 2032.


The growth of this market can be attributed to factors such as increasing volume of ongoing research activities & clinical trials and development of complex therapeutic modalities, such as gene therapies as well as biologics. Also, increased outsourcing laboratory testing services and growing development and approval of biopharmaceutical are expected to fuel the market growth. Also, outsourcing these services enable companies to access testing facilities in different geographical regions. This globalization of testing capabilities allows companies to expand their market reach, establish strategic partnerships, and leverage regional expertise and resources to support drug development activities in diverse markets, thereby augmenting the industry growth.

Bioanalytical testing services refer to a range of laboratory services that involve the analysis of biological samples such as blood, urine, tissue, etc. to quantify the concentration of drugs, metabolites, biomarkers, and other analytes in biological matrices. These services are commonly used in the pharmaceutical and biotechnology industries for various purposes, including drug development, pharmacokinetic studies, bioequivalence assessments, and in overall clinical trials.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for bioanalytical testing services was valued at USD 3.8 billion in 2023 and is predicted to reach USD 8.1 billion by 2032, attributed to the increasing volume of ongoing research activities & clinical trials, along with the development of complex therapeutic modalities.

The small molecule segment accounted for major market share of 56.1% in 2023 and is expected to dominate through 2032 attributed to the advancements in medical science concerning small molecules and the growing demand to address unmet medical needs.

North America market for bioanalytical testing services accounted for USD 1.6 billion in 2023 and is anticipated to observe 8.4% CAGR between 2024-2032 owing to the increasing investment in the R&D of new drugs by pharmaceutical and biotechnology companies.

BioAgilytix, Charles River Laboratories, Inc., Eurofins Scientific, Frontage Labs, ICON Plc, Intertek Group Plc, Labcorp Drug Development, Pace Analytical Services LLC, SGS Société Générale de Surveillance SA, Syneos Health, Thermo Fisher Scientific Inc., and WuXi AppTec

Bioanalytical Testing Services Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 266
  • Countries covered: 19
  • Pages: 195
 Download Free Sample